Novo Nordisk invests $4bn to expand weight loss drug production in US
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand